The curtain is coming down on Broadway's 'Death Becomes Her', a musical adaptation of the 1992 film. This production, which opened in November 2024, will end its run on June 28, 2026, after a successful but not without challenges, 20-month journey. The show, directed and choreographed by Christopher Gattelli, with a book by Marco Pennette and an original score by Julia Mattison and Noel Carey, received 10 Tony nominations, tying for the most nominations of the 2024-2025 season. While it took home the award for best costume design, the musical's grosses and attendance had been slumping since January, with the week ending May 10 bringing in just over $760,000. This decline in performance, despite its initial success, raises questions about the longevity and appeal of such adaptations on the Broadway stage.
The lead roles of Madeline Ashton and Helen Sharp were originated by Megan Hilty and Jennifer Simard, both of whom were Tony-nominated for their performances. Hilty played her final performance on January 11, 2026, marking a significant moment in the show's history. The current cast includes Simard, Betsy Wolfe, Christopher Sieber, Michelle Williams, Taurean Everett, and Josh Lamon, each bringing their unique talents to the stage. The musical's success in terms of nominations and awards, despite the eventual decline in attendance and revenue, highlights the complex dynamics between critical acclaim and commercial performance in the theater industry.
The producers, Lowe Cunningham, expressed pride in the show's achievements, acknowledging the hard work of every artist, musician, and crew member involved. They also announced a multiyear North American tour, set to begin in September 2026 at Playhouse Square in Cleveland, OH, ensuring that the show's legacy will continue beyond its Broadway run. This decision to tour is a strategic move to sustain the show's popularity and reach a wider audience, a common strategy in the theater world to extend the life of a successful production.
The story of 'Death Becomes Her' on Broadway serves as a reminder of the challenges and opportunities in the theater industry. While the show's initial success and critical acclaim are commendable, the eventual decline in performance underscores the need for strategic planning and adaptability. The upcoming tour is a testament to the producers' faith in the show's enduring appeal, and it remains to be seen whether this move will reignite the show's popularity or if it will be a case of too little, too late. The theater world awaits with bated breath, hoping that 'Death Becomes Her' will find a new lease of life and continue to captivate audiences across the country and beyond.
